+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Superdisintegrants Market 2019-2025

  • PDF Icon


  • August 2019
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 4845284
Global Superdisintegrants Market Size, Share & Trends Analysis Report by Product Type (Synthetic Superdisintegrants and Natural Superdisintegrants), by Formulation (Capsules and Tablets), and by Therapeutic Area (Infectious Diseases, Cardiovascular Diseases, Hematological Diseases, Neurological Diseases, Oncology, and Others) and Forecast, 2019-2025.

Excipients are integral non-therapeutic material used in the manufacturing, designing and development of a drug from active molecules. Superdisintegrants are the excipients used in the pharmaceutical industries for tablet-based drug delivery, as it aids them to disintegrate when submerged in liquid. Superdisintegrants plays a vital role in the reduction of disintegration time of oral solid dosage forms such as pills, capsules, and tablets, thus enhancing their efficiency. Owing to this benefit, these are greatly used in the manufacturing of disintegrants oral formulations, which further increases the demand for superdisintegrants in the market. Superdisintegrants are available in synthetic and natural product types and are used for a wide range of applications or therapeutic areas such as infectious diseases, CVD, hematological diseases, neurological diseases, gastrointestinal diseases, inflammatory diseases, and oncology.

Based on the geography, the global superdisintegrants market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. Asia-Pacific is anticipated to show considerable growth in the global superdisintegrants market. This is attributed the high investments in the healthcare sector and increasing outsourcing of excipients to the drug manufacturing countries such as India and China. The prevalent use of sodium starch glycolate in orally and fast integrating tablets along with the adoption of new drug delivery system technologies are some other factors propelling the market growth in Asia-Pacific.

The prominent players functioning in the global superdisintegrants market are BASF SE, Asahi Kasei Corp., Ashland Inc., DFE Pharma, FMC Corp., JRS Pharma LP, Evonik Industries AG, and Roquette Freres S.A., among others. Manufacturers are gradually more investing in product development and innovation of novel formulations, in order to gain a competitive share. For instance, in 2017, Roquette completed the acquisition of Itacel, the excipient division of Blanver in Brazil. This acquisition will assist in the expansion of the company’s pharmaceutical excipient business in the Americas, owing to the large presence of Itacel in the region.

Research Methodology

The market study of the global superdisintegrants market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalogue

The report is intended for pharmaceutical industries and government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:
1. Global Superdisintegrants Market Research and Analysis by Product Type
2. Global Superdisintegrants Market Research and Analysis by Formulation
3. Global Superdisintegrants Market Research and Analysis by Therapeutic Area

The Report Covers:
  • Comprehensive research methodology of the global superdisintegrants market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global superdisintegrants market.
  • Insights about market determinants which are stimulating the global superdisintegrants market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. BASF SE Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. DFE Pharma Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. Asahi Kasei Corp. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. Ashland Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. Roquette Freres S.A. Overview Financial Analysis SWOT Analysis Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Superdisintegrants Market by Product Type
5.1.1. Synthetic Superdisintegrants
5.1.2. Natural Superdisintegrants
5.2. Global Superdisintegrants Market by Formulation
5.2.1. Capsules
5.2.2. Tablets
5.3. Global Superdisintegrants Market by Therapeutic Area
5.3.1. Infectious Diseases
5.3.2. CVD
5.3.3. Hematological Diseases
5.3.4. Neurological Diseases
5.3.5. Oncology
5.3.6. Others (Inflammatory Diseases)
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Asahi Kasei Corp.
7.2. Ashland Inc.
7.3. BASF SE
7.4. Corel Pharma Chem
7.5. DFE Pharma
7.6. Evonik Industries AG
7.7. FMC Corp.
7.8. JRS Pharma LP
7.9. Kerry Group
7.10. Merck KGaA
7.11. Roquette Freres S.A.
7.12. Sigachi Industries Pvt. Ltd.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Asahi Kasei Corp.
  • Ashland Inc.
  • Corel Pharma Chem
  • DFE Pharma
  • Evonik Industries AG
  • FMC Corp.
  • JRS Pharma LP
  • Kerry Group
  • Merck KGaA
  • Roquette Freres S.A.
  • Sigachi Industries Pvt. Ltd.